These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30963195)

  • 21. MRI gadolinium-based contrast agents. Radiologists beware!
    Goullé JP; Cattanéo A; Saussereau E; Mahieu L; Guerbet M; Lacroix C
    Ann Pharm Fr; 2009 Sep; 67(5):335-9. PubMed ID: 19695369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular gadolinium contrast agents: differences in stability.
    Morcos SK
    Eur J Radiol; 2008 May; 66(2):175-9. PubMed ID: 18343072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrogenic systemic fibrosis: more questions and some answers.
    Morcos SK; Thomsen HS
    Nephron Clin Pract; 2008; 110(1):c24-31; discussion c32. PubMed ID: 18688172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadolinium toxicity and treatment.
    Ramalho J; Ramalho M; Jay M; Burke LM; Semelka RC
    Magn Reson Imaging; 2016 Dec; 34(10):1394-1398. PubMed ID: 27693607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms.
    Rogosnitzky M; Branch S
    Biometals; 2016 Jun; 29(3):365-76. PubMed ID: 27053146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gadolinium contrast agents - are they really safe?
    Malikova H; Holesta M
    J Vasc Access; 2017 Mar; 18(Suppl. 2):1-7. PubMed ID: 28362042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Levels of Gadolinium Deposition in the Skin of a Patient With Normal Renal Function.
    Roberts DR; Lindhorst SM; Welsh CT; Maravilla KR; Herring MN; Braun KA; Thiers BH; Davis WC
    Invest Radiol; 2016 May; 51(5):280-9. PubMed ID: 26953564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
    Thakral C; Abraham JL
    J Cutan Pathol; 2009 Dec; 36(12):1244-54. PubMed ID: 19602073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nephrogenic systemic fibrosis].
    Breitschaft A; Stahlmann R
    Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics of gadolinium-based contrast agents].
    Czock D
    Radiologe; 2019 May; 59(5):408-412. PubMed ID: 30725143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gadolinium-containing magnetic resonance contrast media: investigation on the possible transchelation of Gd³⁺ to the glycosaminoglycan heparin.
    Taupitz M; Stolzenburg N; Ebert M; Schnorr J; Hauptmann R; Kratz H; Hamm B; Wagner S
    Contrast Media Mol Imaging; 2013; 8(2):108-16. PubMed ID: 23281283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update.
    Idée JM; Fretellier N; Robic C; Corot C
    Crit Rev Toxicol; 2014 Nov; 44(10):895-913. PubMed ID: 25257840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gadolinium-based contrast agents in children.
    Rozenfeld MN; Podberesky DJ
    Pediatr Radiol; 2018 Aug; 48(9):1188-1196. PubMed ID: 30078039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephrogenic systemic fibrosis: a report of 29 cases.
    Shabana WM; Cohan RH; Ellis JH; Hussain HK; Francis IR; Su LD; Mukherji SK; Swartz RD
    AJR Am J Roentgenol; 2008 Mar; 190(3):736-41. PubMed ID: 18287446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.
    Stojanov D; Aracki-Trenkic A; Benedeto-Stojanov D
    Neuroradiology; 2016 May; 58(5):433-41. PubMed ID: 26873830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.
    Wei H; Bruns OT; Kaul MG; Hansen EC; Barch M; Wiśniowska A; Chen O; Chen Y; Li N; Okada S; Cordero JM; Heine M; Farrar CT; Montana DM; Adam G; Ittrich H; Jasanoff A; Nielsen P; Bawendi MG
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2325-2330. PubMed ID: 28193901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of Contrast Material Use in Children.
    Soares BP; Lequin MH; Huisman TAGM
    Magn Reson Imaging Clin N Am; 2017 Nov; 25(4):779-785. PubMed ID: 28964467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contemporary applications and limitations of magnetic resonance imaging contrast materials.
    Natalin RA; Prince MR; Grossman ME; Silvers D; Landman J
    J Urol; 2010 Jan; 183(1):27-33. PubMed ID: 19913804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporation of excess gadolinium into human bone from medical contrast agents.
    Darrah TH; Prutsman-Pfeiffer JJ; Poreda RJ; Ellen Campbell M; Hauschka PV; Hannigan RE
    Metallomics; 2009 Nov; 1(6):479-88. PubMed ID: 21305156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is it safe to use gadolinium-based contrast agents in MRI?
    Pullicino R; Das K
    J R Coll Physicians Edinb; 2017 Sep; 47(3):243-246. PubMed ID: 29465099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.